Bioanalytical
TLC uncovers secret of ACTH pharma benefits
May 18 2010
Researchers at Lunds University, Sweden, note the numerous known pharmaceutical benefits of treatment with ACTH.
They include a 30 to 40 per cent reduction in LDL cholesterol and lower levels of lipoproteins which contain apolipoprotein.
ACTH is also known to be beneficial for people with multiple sclerosis and in the treatment of infantile spasms.
However, it is its action on the patient's lipid profile that interested researchers, as the link was known but was not accounted for due to the induction of steroid hormone synthesis.
By extracting secreted lipids and separating them using TLC, the researchers were able to discover that the effect is not a direct interaction between ACTH and lipid synthesis.
Rather, it is mediated by the inhibition of lipoproteins which contain apolipoprotein B, in turn lowering the plasma lipid levels of the individual.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Apr 09 2024 Munich, Germany
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain